Brief: Citius Pharmaceuticals Inc. Reports Fiscal Second Quarter 2023 Financial Results
12/05/2023 21:38
May 12 (Reuters) - Citius Pharmaceuticals Inc CTXR.O :
* CITIUS PHARMACEUTICALS INC REPORTS FISCAL SECOND QUARTER
2023
FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
* CITIUS PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.07
* CITIUS PHARMACEUTICALS INC - $29.1 MILLION IN CASH AND
CASH
EQUIVALENTS AS OF MARCH 31, 2023
* CITIUS PHARMACEUTICALS INC - $15 MILLION REGISTERED DIRECT
OFFERING IN MAY 2023 EXTENDS RUNWAY THROUGH MAY 2024
Source text for Eikon: ID:nPn9GFjYHa
Further company coverage: CTXR.O
((Reutersbriefs@thomsonreuters.com;))
Recent news on Citius Pharmaceuticals
See all newsCitius Pharmaceuticals Q2 revenue rises on LYMPHIR launch
Citius Pharmaceuticals reports first revenue of $3.9 mln
Brief: Citius Oncology Expands International Distribution Of Lymphir™ To European Union Through Exclusive Agreement With Uniphar
Brief: Citius Pharmaceuticals, Inc. Reports Fiscal Year 2025 Financial Results And Provides Business Update
Brief: Citius Oncology Announces $18 Million Concurrent Registered Direct Offering And Private Placement Priced At-The-Market Under Nasdaq Rules